FINWIRES · TerminalLIVE
FINWIRES

Wolfe Upgrades Biogen to Outperform From Peer Perform, Price Target is $300

By

Biogen (BIIB) has an average rating of overweight and mean price target of $239.63, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles